# Drug Interaction Study Between Erdosteine and Bepotastine Besilate in Healthy Adult Volunteers

> **NCT02332044** · PHASE1 · COMPLETED · sponsor: **Daewoong Pharmaceutical Co. LTD.** · enrollment: 36 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Erdos
- **DRUG:** Talion
- **DRUG:** Erdos, Talion

## Key facts

- **NCT ID:** NCT02332044
- **Lead sponsor:** Daewoong Pharmaceutical Co. LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2014-09
- **Final completion:** 2015-01
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2015-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02332044

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02332044, "Drug Interaction Study Between Erdosteine and Bepotastine Besilate in Healthy Adult Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02332044. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*